These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16625480)

  • 21. BCG sepsis following inadvertent intravenous BCG administration for the treatment of bladder cancer can be effectively cured with anti-tuberculosis medications.
    Akbulut Z; Canda AE; Atmaca AF; Cimen HI; Hasanoglu C; Balbay MD
    N Z Med J; 2010 Nov; 123(1325):72-7. PubMed ID: 21317964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [BCG therapy. Its role in the treatment of tumors of the bladder].
    Patard JJ; Chopin DK; Abbou CC
    Ann Urol (Paris); 1995; 29(5):292-3. PubMed ID: 8638911
    [No Abstract]   [Full Text] [Related]  

  • 23. [Systemic infection secondary to intravesical BCG instillation].
    Fernández Cañabate E; Longoni Merino M
    Farm Hosp; 2006; 30(5):317-9. PubMed ID: 17166070
    [No Abstract]   [Full Text] [Related]  

  • 24. [Systemic BCG reactions after intravesical BCG therapy. A report of four cases].
    Sfaxi M; Langar H; Ouni A; Riahi Y; El Aidli S; Daghfous R; Ben Abdeladhim A; Chébil M
    Therapie; 2008; 63(1):43-7. PubMed ID: 18387275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCG and bladder cancer.
    Gilling PJ
    N Z Med J; 2010 Nov; 123(1325):8-9. PubMed ID: 21317955
    [No Abstract]   [Full Text] [Related]  

  • 26. Four cases of disseminated Mycobacterium bovis infection following intravesical BCG instillation for treatment of bladder carcinoma.
    Nadasy KA; Patel RS; Emmett M; Murillo RA; Tribble MA; Black RD; Sutker WL
    South Med J; 2008 Jan; 101(1):91-5. PubMed ID: 18176300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An unusual cause of retention of urine after intravesical Bacillus Calmette-Guérin therapy for superficial bladder cancer.
    Cheung JM; Hou SS; Yip SK; Ng CF
    Hong Kong Med J; 2011 Dec; 17(6):492-4. PubMed ID: 22147321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies for optimizing bacillus Calmette-Guérin.
    Shah JB; Kamat AM
    Urol Clin North Am; 2013 May; 40(2):211-8. PubMed ID: 23540779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BCGitis: A rare complication after intravesical BCG therapy.
    Oliveira MJ; Vaz D; Carvalho A; Braga R; Duarte R
    J Bras Pneumol; 2015; 41(5):480-1. PubMed ID: 26578142
    [No Abstract]   [Full Text] [Related]  

  • 30. BCGitis detected by (18)F-FDG PET/CT after treatment of bladder urothelial carcinoma.
    Jiménez Londoño GA; García Vicente AM; Ros Izquierdo J; Tello Galán MJ; González García B; Pena Pardo FJ; Palomar Muñoz A; Soriano Castrejón ÁM
    Rev Esp Med Nucl Imagen Mol; 2016; 35(2):141-2. PubMed ID: 26522000
    [No Abstract]   [Full Text] [Related]  

  • 31. Sputum-positive lung tuberculosis after instillation of BCG for bladder cancer.
    Höffler D; Niemeyer R; Strack G; Zieschang M
    Clin Nephrol; 1991 Dec; 36(6):307. PubMed ID: 1769146
    [No Abstract]   [Full Text] [Related]  

  • 32. Hazards of early BCG vaccination: BCGitis in a patient with chronic granulomatous disease.
    Kawashima H; Hasegawa D; Nakamura M; Mochizuki S; Kashiwagi Y; Nishimata S; Sato S; Sasamoto M; Takekuma K; Hoshika A; Nunoi H
    Pediatr Int; 2007 Jun; 49(3):418-9. PubMed ID: 17532851
    [No Abstract]   [Full Text] [Related]  

  • 33. Cutaneous BCG of the penis after intravesical therapy for bladder cancer: a case report in a 66-year-old male.
    Hillyer S; Gulmi FA
    Can J Urol; 2009 Oct; 16(5):4866-9. PubMed ID: 19796470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Getting the Most Out of bacillus Calmette-Guérin for Treatment of Bladder Cancer.
    Lamm DL
    J Urol; 2016 Jan; 195(1):7-8. PubMed ID: 26456281
    [No Abstract]   [Full Text] [Related]  

  • 35. BCG immunotherapy--from pathophysiology to clinical practice.
    Tishler M; Shoenfeld Y
    Expert Opin Drug Saf; 2006 Mar; 5(2):225-9. PubMed ID: 16503744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transient anuria requiring nephrostomy after intravesical bacillus Calmette-Guérin instillations for superficial bladder cancer.
    Kaneko T; Fujita K; Homma Y
    Int J Urol; 2006 Mar; 13(3):294-5. PubMed ID: 16643629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Editorial comment.
    Kamat AM
    J Urol; 2009 Nov; 182(5):2203. PubMed ID: 19758663
    [No Abstract]   [Full Text] [Related]  

  • 38. [ BCG-immunotherapy and bladder cancer].
    Rischmann P
    Prog Urol; 2008 May; 18 Suppl 5():S93. PubMed ID: 18585633
    [No Abstract]   [Full Text] [Related]  

  • 39. Ocular involvement following Bacillus Calmette-Guerin immunotherapy for bladder carcinoma.
    Cugati S; Gilhotra JS; Lake S; Gordon DL
    Clin Exp Ophthalmol; 2014 Jul; 42(5):494-5. PubMed ID: 24372891
    [No Abstract]   [Full Text] [Related]  

  • 40. Costal BCG osteomyelitis developing 1 year after BCG vaccination.
    Oyachi N; Obana K; Suzuki T; Kimura S; Chino K; Oyama T; Takano K
    Pediatr Int; 2013 Oct; 55(5):641-3. PubMed ID: 24134752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.